Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)
Condition(s):Myelogenous Leukemia, ChronicLast Updated:September 20, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Myelogenous Leukemia, ChronicLast Updated:September 20, 2016Completed
Condition(s):Hepatitis C, ChronicLast Updated:October 31, 2016Completed
Condition(s):Hepatitis B, ChronicLast Updated:August 31, 2017Completed
Condition(s):Hepatitis B, ChronicLast Updated:April 10, 2017Completed
Condition(s):Hepatitis B, ChronicLast Updated:November 2, 2016Completed
Condition(s):Hepatitis B, ChronicLast Updated:November 2, 2016Completed
Condition(s):Hepatitis B, ChronicLast Updated:July 30, 2013Completed
Condition(s):Hepatitis D, ChronicLast Updated:July 15, 2016Completed
Condition(s):Hepatitis B, ChronicLast Updated:October 24, 2016Completed
Condition(s):Hepatitis B, ChronicLast Updated:February 6, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.